{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T19:06:41Z","timestamp":1761419201845,"version":"3.37.3"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4-5","license":[{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA66572"],"award-info":[{"award-number":["U01CA66572"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Causes Control"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10552-018-1020-5","type":"journal-article","created":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T03:51:26Z","timestamp":1520394686000},"page":"417-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pre-diagnostic aspirin use and mortality after breast cancer"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9001-186X","authenticated-orcid":false,"given":"Tengteng","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humberto","family":"Parada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen M.","family":"McClain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick T.","family":"Bradshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Beth","family":"Terry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan L.","family":"Teitelbaum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred I.","family":"Neugut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marilie D.","family":"Gammon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,7]]},"reference":[{"key":"1020_CR1","volume-title":"Cancer facts figs","author":"American Cancer Society","year":"2017","unstructured":"American Cancer Society (2017) Cancer facts & figures 2017. American Cancer Society, Atlanta"},{"issue":"1","key":"1020_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3322\/caac.21320","volume":"66","author":"CE DeSantis","year":"2016","unstructured":"DeSantis CE, Fedewa SA, Goding Sauer A, Kramer JL, Smith RA, Jemal A (2016) Breast cancer statistics, 2015: Convergence of incidence rates between black and white women. Cancer J Clin 66(1):31\u201342","journal-title":"Cancer J Clin"},{"issue":"8","key":"1020_CR3","first-page":"3559","volume":"43","author":"CA Carter","year":"1983","unstructured":"Carter CA, Milholland RJ, Shea W, Ip MM (1983) Effect of the prostaglandin synthetase inhibitor indomethacin on 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats fed different levels of fat. Cancer Res 43(8):3559\u20133562","journal-title":"Cancer Res"},{"issue":"1","key":"1020_CR4","first-page":"71","volume":"6","author":"RE Harris","year":"1999","unstructured":"Harris RE, Kasbari S, Farrar WB (1999) Prospective study of nonsteroidal anti-inflammatory drugs and breast cancer. Oncol Rep 6(1):71\u201373","journal-title":"Oncol Rep"},{"issue":"12","key":"1020_CR5","first-page":"1586","volume":"11","author":"TW Johnson","year":"2002","unstructured":"Johnson TW, Anderson KE, Lazovich D, Folsom AR (2002) Association of aspirin and nonsteroidal anti-inflammatory drug use with breast cancer. Cancer Epidemiol Biomark Prevent 11(12):1586\u20131591","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"3","key":"1020_CR6","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/sj.bjc.6602003","volume":"91","author":"LA Garcia Rodriguez","year":"2004","unstructured":"Garcia Rodriguez LA, Gonzalez-Perez A (2004) Risk of breast cancer among users of aspirin and other anti-inflammatory drugs. Br J Cancer 91(3):525\u2013529","journal-title":"Br J Cancer"},{"issue":"8","key":"1020_CR7","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1093\/jnci\/djk132","volume":"99","author":"EJ Jacobs","year":"2007","unstructured":"Jacobs EJ, Thun MJ, Bain EB, Rodriguez C, Henley SJ, Calle EE (2007) A large cohort study of long-term daily use of adult-strength aspirin and cancer incidence. J Natl Cancer Inst 99(8):608\u2013615","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"1020_CR8","doi-asserted-by":"publisher","first-page":"2433","DOI":"10.1001\/jama.291.20.2433","volume":"291","author":"MB Terry","year":"2004","unstructured":"Terry MB, Gammon MD, Zhang FF et al (2004) Association of frequency and duration of aspirin use and hormone receptor status with breast cancer risk. JAMA 291(20):2433\u20132440","journal-title":"JAMA"},{"issue":"5","key":"1020_CR9","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/S1470-2045(12)70112-2","volume":"13","author":"AM Algra","year":"2012","unstructured":"Algra AM, Rothwell PM (2012) Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 13(5):518\u2013527","journal-title":"Lancet Oncol"},{"issue":"9","key":"1020_CR10","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1200\/JCO.2009.22.7918","volume":"28","author":"MD Holmes","year":"2010","unstructured":"Holmes MD, Chen WY, Li L, Hertzmark E, Spiegelman D, Hankinson SE (2010) Aspirin intake and survival after breast cancer. J Clin Oncol 28(9):1467\u20131472","journal-title":"J Clin Oncol"},{"issue":"6","key":"1020_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s10552-007-9003-y","volume":"18","author":"ML Kwan","year":"2007","unstructured":"Kwan ML, Habel LA, Slattery ML, Caan B (2007) NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control 18(6):613\u2013620","journal-title":"Cancer Causes Control"},{"issue":"3","key":"1020_CR12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/bjc.2014.264","volume":"111","author":"DM Fraser","year":"2014","unstructured":"Fraser DM, Sullivan FM, Thompson AM, McCowan C (2014) Aspirin use and survival after the diagnosis of breast cancer: a population-based cohort study. Br J Cancer 111(3):623\u2013627","journal-title":"Br J Cancer"},{"issue":"4","key":"1020_CR13","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/EDE.0000000000000480","volume":"27","author":"DP Cronin-Fenton","year":"2016","unstructured":"Cronin-Fenton DP, Heide-Jorgensen U, Ahern TP et al (2016) Low-dose aspirin, nonsteroidal anti-inflammatory drugs, selective COX-2 inhibitors and breast cancer recurrence. Epidemiology 27(4):586\u2013593","journal-title":"Epidemiology"},{"issue":"11","key":"1020_CR14","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1158\/1055-9965.EPI-15-0452","volume":"24","author":"S Zhong","year":"2015","unstructured":"Zhong S, Chen L, Zhang X, Yu D, Tang J, Zhao J (2015) Aspirin use and risk of breast cancer: systematic review and meta-analysis of observational studies. Cancer Epidemiol Biomark Prevent 24(11):1645\u20131655","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"1","key":"1020_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s10549-015-3300-z","volume":"150","author":"S Zhong","year":"2015","unstructured":"Zhong S, Zhang X, Chen L, Ma T, Tang J, Zhao J (2015) Association between aspirin use and mortality in breast cancer patients: a meta-analysis of observational studies. Breast Cancer Res Treat 150(1):199\u2013207","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"1020_CR16","doi-asserted-by":"publisher","first-page":"4446","DOI":"10.1158\/0008-5472.CAN-13-3603","volume":"74","author":"LW Bowers","year":"2014","unstructured":"Bowers LW, Maximo IX, Brenner AJ et al (2014) NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions. Cancer Res 74(16):4446\u20134457","journal-title":"Cancer Res"},{"issue":"8","key":"1020_CR17","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1001\/jama.2014.732","volume":"311","author":"CL Ogden","year":"2014","unstructured":"Ogden CL, Carroll MD, Kit BK, Flegal KM (2014) Prevalence of childhood and adult obesity in the United States, 2011\u20132012. JAMA 311(8):806\u2013814","journal-title":"JAMA"},{"issue":"3","key":"1020_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/1097-0215(20000520)89:3<293::AID-IJC13>3.0.CO;2-R","volume":"89","author":"GK Reeves","year":"2000","unstructured":"Reeves GK, Patterson J, Vessey MP, Yeates D, Jones L (2000) Hormonal and other factors in relation to survival among breast cancer patients. Int J Cancer 89(3):293\u2013299","journal-title":"Int J Cancer"},{"issue":"1","key":"1020_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.7326\/0003-4819-116-1-26","volume":"116","author":"RT Senie","year":"1992","unstructured":"Senie RT, Rosen PP, Rhodes P, Lesser ML, Kinne DW (1992) Obesity at diagnosis of breast carcinoma influences duration of disease-free survival. Annals of internal medicine 116(1):26\u201332","journal-title":"Annals of internal medicine"},{"issue":"17","key":"1020_CR20","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1056\/NEJMoa021423","volume":"348","author":"EE Calle","year":"2003","unstructured":"Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Eng J Med 348(17):1625\u20131638","journal-title":"N Eng J Med"},{"issue":"4","key":"1020_CR21","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1200\/JCO.2002.20.4.1128","volume":"20","author":"RT Chlebowski","year":"2002","unstructured":"Chlebowski RT, Aiello E, McTiernan A (2002) Weight loss in breast cancer patient management. J Clin Oncol 20(4):1128\u20131143","journal-title":"J Clin Oncol"},{"issue":"2","key":"1020_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10549-007-9785-3","volume":"111","author":"B Majed","year":"2008","unstructured":"Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B (2008) Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat 111(2):329\u2013342","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1020_CR23","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s10549-010-0990-0","volume":"123","author":"M Protani","year":"2010","unstructured":"Protani M, Coory M, Martin JH (2010) Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat 123(3):627\u2013635","journal-title":"Breast Cancer Res Treat"},{"issue":"16","key":"1020_CR24","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1093\/jnci\/djg022","volume":"95","author":"TJ Key","year":"2003","unstructured":"Key TJ, Appleby PN, Reeves GK et al (2003) Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst 95(16):1218\u20131226","journal-title":"J Natl Cancer Inst"},{"issue":"11","key":"1020_CR25","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.3390\/nu6114760","volume":"6","author":"JM Monk","year":"2014","unstructured":"Monk JM, Turk HF, Liddle DM et al (2014) n-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer. Nutrients 6(11):4760\u20134793","journal-title":"Nutrients"},{"issue":"3","key":"1020_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1023\/A:1016387020854","volume":"74","author":"MD Gammon","year":"2002","unstructured":"Gammon MD, Neugut AI, Santella RM et al (2002) The Long Island Breast Cancer Study Project: description of a multi-institutional collaboration to identify environmental risk factors for breast cancer. Breast Cancer Res Treat 74(3):235\u2013254","journal-title":"Breast Cancer Res Treat"},{"issue":"7","key":"1020_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1007\/s10552-012-9989-7","volume":"23","author":"RJ Cleveland","year":"2012","unstructured":"Cleveland RJ, North KE, Stevens J, Teitelbaum SL, Neugut AI, Gammon MD (2012) The association of diabetes with breast cancer incidence and mortality in the Long Island Breast Cancer Study Project. Cancer Causes Control 23(7):1193\u20131203","journal-title":"Cancer Causes Control"},{"key":"1020_CR28","unstructured":"CDC. (2014) National Death Index [Internet] Available \n                    http:\/\/www.cdc.gov\/nchs\/ndi.htm\n                    \n                  . Accessed 12 April 2016)"},{"key":"1020_CR29","volume-title":"Modelling survival data in medical research","author":"D Collett","year":"2003","unstructured":"Collett D (2003) Modelling survival data in medical research. Chapman & Hall\/CRC Press LLC, Boca Raton"},{"key":"1020_CR30","unstructured":"Allison P (2010) Survival analysis using SAS: a practical guide"},{"issue":"1","key":"1020_CR31","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00001648-199901000-00008","volume":"10","author":"S Greenland","year":"1999","unstructured":"Greenland S, Pearl J, Robins JM (1999) Causal diagrams for epidemiologic research. Epidemiology 10(1):37\u201348","journal-title":"Epidemiology"},{"issue":"4","key":"1020_CR32","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/EDE.0b013e3181a819a1","volume":"20","author":"EF Schisterman","year":"2009","unstructured":"Schisterman EF, Cole SR, Platt RW (2009) Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology 20(4):488\u2013495","journal-title":"Epidemiology"},{"issue":"15","key":"1020_CR33","doi-asserted-by":"publisher","first-page":"4065","DOI":"10.1158\/0008-5472.CAN-13-2679","volume":"74","author":"TI Barron","year":"2014","unstructured":"Barron TI, Flahavan EM, Sharp L, Bennett K, Visvanathan K (2014) Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study. Cancer Res 74(15):4065\u20134077","journal-title":"Cancer Res"},{"issue":"1","key":"1020_CR34","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1158\/1055-9965.EPI-11-1012","volume":"21","author":"Y Li","year":"2012","unstructured":"Li Y, Brasky TM, Nie J et al (2012) Use of nonsteroidal anti-inflammatory drugs and survival following breast cancer diagnosis. Cancer Epidemiol Biomark Prevent 21(1):239\u2013242","journal-title":"Cancer Epidemiol Biomark Prevent"},{"issue":"2","key":"1020_CR35","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10549-014-3099-z","volume":"147","author":"EH Allott","year":"2014","unstructured":"Allott EH, Tse CK, Olshan AF, Carey LA, Moorman PG, Troester MA (2014) Non-steroidal anti-inflammatory drug use, hormone receptor status, and breast cancer-specific mortality in the Carolina Breast Cancer Study. Breast Cancer Res Treat 147(2):415\u2013421","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"1020_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/EDE.0000000000000394","volume":"27","author":"PT Bradshaw","year":"2016","unstructured":"Bradshaw PT, Stevens J, Khankari N, Teitelbaum SL, Neugut AI, Gammon MD (2016) Cardiovascular disease mortality among breast cancer survivors. Epidemiology 27(1):6\u201313","journal-title":"Epidemiology"},{"issue":"2","key":"1020_CR37","doi-asserted-by":"publisher","first-page":"R34","DOI":"10.1186\/bcr3638","volume":"16","author":"LJ Murray","year":"2014","unstructured":"Murray LJ, Cooper JA, Hughes CM, Powe DG, Cardwell CR (2014) Post-diagnostic prescriptions for low-dose aspirin and breast cancer-specific survival: a nested case\u2013control study in a breast cancer cohort from the UK Clinical Practice Research Datalink. Breast Cancer Res 16(2):R34","journal-title":"Breast Cancer Res"},{"issue":"13","key":"1020_CR38","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1002\/cncr.30004","volume":"122","author":"MC Bradley","year":"2016","unstructured":"Bradley MC, Black A, Freedman AN, Barron TI (2016) Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: a cohort study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer 122(13):2067\u20132075","journal-title":"Cancer"},{"issue":"6","key":"1020_CR39","first-page":"1322","volume":"53","author":"MJ Thun","year":"1993","unstructured":"Thun MJ, Namboodiri MM, Calle EE, Flanders WD, Heath CW Jr. (1993) Aspirin use and risk of fatal cancer. Cancer Res 53(6):1322\u20131327","journal-title":"Cancer Res"},{"issue":"5b","key":"1020_CR40","first-page":"3177","volume":"24","author":"LD Ratnasinghe","year":"2004","unstructured":"Ratnasinghe LD, Graubard BI, Kahle L, Tangrea JA, Taylor PR, Hawk E (2004) Aspirin use and mortality from cancer in a prospective cohort study. Anticancer Res 24(5b):3177\u20133184","journal-title":"Anticancer Res"},{"issue":"20","key":"1020_CR41","doi-asserted-by":"publisher","first-page":"2488","DOI":"10.1001\/jama.291.20.2488","volume":"291","author":"RN DuBois","year":"2004","unstructured":"DuBois RN (2004) Aspirin and breast cancer prevention: the estrogen connection. JAMA 291(20):2488\u20132489","journal-title":"JAMA"},{"issue":"11","key":"1020_CR42","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1093\/jnci\/dji140","volume":"97","author":"SF Marshall","year":"2005","unstructured":"Marshall SF, Bernstein L, Anton-Culver H et al (2005) Nonsteroidal anti-inflammatory drug use and breast cancer risk by stage and hormone receptor status. J Natl Cancer Inst 97(11):805\u2013812","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"1020_CR43","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/bcr1678","volume":"9","author":"LR Howe","year":"2007","unstructured":"Howe LR (2007) Inflammation and breast cancer. Cyclooxygenase\/prostaglandin signaling and breast cancer. Breast Cancer Res 9(4):210","journal-title":"Breast Cancer Res"},{"issue":"2","key":"1020_CR44","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s10549-014-3030-7","volume":"146","author":"Y Cui","year":"2014","unstructured":"Cui Y, Deming-Halverson SL, Shrubsole MJ et al (2014) Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women. Breast Cancer Res Treat 146(2):439\u2013446","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"1020_CR45","first-page":"632","volume":"62","author":"A Ristimaki","year":"2002","unstructured":"Ristimaki A, Sivula A, Lundin J et al (2002) Prognostic significance of elevated cyclooxygenase-2 expression in breast cancer. Cancer Res 62(3):632\u2013635","journal-title":"Cancer Res"},{"issue":"4","key":"1020_CR46","doi-asserted-by":"publisher","first-page":"e0152402","DOI":"10.1371\/journal.pone.0152402","volume":"11","author":"PC Elwood","year":"2016","unstructured":"Elwood PC, Morgan G, Pickering JE et al (2016) Aspirin in the treatment of cancer: reductions in metastatic spread and in mortality: a systematic review and meta-analyses of published studies. PLoS ONE 11(4):e0152402","journal-title":"PLoS ONE"},{"issue":"10","key":"1020_CR47","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1158\/1940-6207.CAPR-12-0171","volume":"5","author":"PK Dhillon","year":"2012","unstructured":"Dhillon PK, Kenfield SA, Stampfer MJ, Giovannucci EL, Chan JM. Aspirin use after a prostate cancer diagnosis and cancer survival in a prospective cohort. Cancer Prevent Res 2012;5(10):1223\u20131228","journal-title":"Cancer Prevent Res"},{"issue":"4b","key":"1020_CR48","first-page":"2997","volume":"19","author":"C Sotiriou","year":"1999","unstructured":"Sotiriou C, Lacroix M, Lagneaux L, Berchem G, Body JJ (1999) The aspirin metabolite salicylate inhibits breast cancer cells growth and their synthesis of the osteolytic cytokines interleukins-6 and -11. Anticancer Res 19(4b):2997\u20133006","journal-title":"Anticancer Res"},{"issue":"9","key":"1020_CR49","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1111\/j.1600-0412.2012.01472.x","volume":"91","author":"HB Ammundsen","year":"2012","unstructured":"Ammundsen HB, Faber MT, Jensen A et al (2012) Use of analgesic drugs and risk of ovarian cancer: results from a Danish case\u2013control study. Acta obstetricia et gynecologica Scandinavica 91(9):1094\u20131102","journal-title":"Acta obstetricia et gynecologica Scandinavica"},{"key":"1020_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2288-11-7","volume":"11","author":"BJ Cairns","year":"2011","unstructured":"Cairns BJ, Liu B, Clennell S et al (2011) Lifetime body size and reproductive factors: comparisons of data recorded prospectively with self reports in middle age. BMC Med Res Methodol 11:7","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"1020_CR51","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s10549-016-3724-0","volume":"156","author":"LE McCullough","year":"2016","unstructured":"McCullough LE, Chen J, Cho YH et al (2016) DNA methylation modifies the association between obesity and survival after breast cancer diagnosis. Breast Cancer Res Treat 156(1):183\u2013194","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"1020_CR52","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/sj.bjc.6606041","volume":"104","author":"AE Coghill","year":"2011","unstructured":"Coghill AE, Newcomb PA, Chia VM et al (2011) Pre-diagnostic NSAID use but not hormone therapy is associated with improved colorectal cancer survival in women. Br J Cancer 104(5):763\u2013768","journal-title":"Br J Cancer"},{"issue":"5","key":"1020_CR53","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic dis 40(5):373\u2013383","journal-title":"J Chronic dis"},{"issue":"14","key":"1020_CR54","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/jnci\/djs264","volume":"104","author":"CA Clarke","year":"2012","unstructured":"Clarke CA, Keegan TH, Yang J et al (2012) Age-specific incidence of breast cancer subtypes: understanding the black-white crossover. J Natl Cancer Inst 104(14):1094\u20131101","journal-title":"J Natl Cancer Inst"},{"issue":"7","key":"1020_CR55","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S1047-2797(01)00285-X","volume":"12","author":"DC Cowper","year":"2002","unstructured":"Cowper DC, Kubal JD, Maynard C, Hynes DM (2002) A primer and comparative review of major US mortality databases. Ann Epidemiol 12(7):462\u2013468","journal-title":"Ann Epidemiol"}],"container-title":["Cancer Causes &amp; Control"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10552-018-1020-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-018-1020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10552-018-1020-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T20:25:55Z","timestamp":1589660755000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10552-018-1020-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,7]]},"references-count":55,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1020"],"URL":"https:\/\/doi.org\/10.1007\/s10552-018-1020-5","relation":{},"ISSN":["0957-5243","1573-7225"],"issn-type":[{"type":"print","value":"0957-5243"},{"type":"electronic","value":"1573-7225"}],"subject":[],"published":{"date-parts":[[2018,3,7]]},"assertion":[{"value":"30 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}